Procalcitonin and Bacterial Infection Markers

Procalcitonin is the peptide precursor of calcitonin whose circulating level rises markedly during systemic bacterial infection while remaining comparatively low in many viral and non-infectious inflammatory states. This relative selectivity has made it the most studied biomarker for distinguishing bacterial infection and sepsis from other causes of inflammation.

Definition

Procalcitonin is the 116-amino-acid precursor of the hormone calcitonin; outside the thyroid C-cells its production is induced broadly in tissues during systemic bacterial infection, so its plasma concentration serves as a relatively bacterial-selective marker of inflammation.

Scope

This entry describes procalcitonin as an analyte: its origin, the stimulus pattern that makes it relatively bacterial-selective, its kinetics, and its general use as a marker in suspected bacterial infection and sepsis, alongside related infection markers. It is a reference description and does not provide diagnostic cut-offs, antibiotic decisions, or treatment protocols.

Core questions

• Why does procalcitonin rise more in bacterial than in viral infection?
• What are the kinetics of procalcitonin after a bacterial stimulus?
• How does procalcitonin compare with CRP as an infection marker?
• What is meant by procalcitonin-guided assessment in research settings?

Key concepts

• Calcitonin precursor peptide
• Bacterial-selective induction
• Cytokine and bacterial-product stimulation
• Suppression by interferon-gamma in viral infection
• Kinetics (rise within hours, daily decline with resolution)
• Sepsis biomarker
• Comparison with CRP specificity

Mechanisms

In health, procalcitonin is produced by thyroid C-cells and cleaved to calcitonin, so plasma levels are very low. During severe systemic bacterial infection, bacterial products such as endotoxin and pro-inflammatory cytokines induce procalcitonin expression in many extrathyroidal tissues, and the unprocessed peptide accumulates in plasma. Viral infections tend to raise interferon-gamma, which attenuates this induction, contributing to the relatively greater rise in bacterial disease. Procalcitonin increases within a few hours of a bacterial stimulus and declines as infection is controlled, giving it kinetics useful for following a course.

Clinical relevance

Procalcitonin is used as a marker that, compared with several other acute-phase reactants, is more closely associated with systemic bacterial infection and sepsis, and it has been studied as a tool to support decisions about antibiotic use in research settings. It is not perfectly specific and must be read with the clinical context; this entry describes the marker and does not give thresholds, antibiotic guidance, or individualized advice.

Epidemiology

Procalcitonin is widely measured in emergency and critical-care settings where bacterial infection and sepsis are common. Systematic review evidence has evaluated its diagnostic performance for sepsis across many studies (Wacker et al., 2013).

Evidence & guidelines

A systematic review and meta-analysis summarizes procalcitonin's diagnostic accuracy for sepsis (Wacker et al., 2013), and randomized work has examined procalcitonin-guided antibiotic strategies in respiratory infection (Christ-Crain et al., 2004); broader sepsis-biomarker context is reviewed by Pierrakos and Vincent (2010). This entry reports that literature at a reference level rather than as guideline direction.

History

Elevated procalcitonin in severe bacterial infection was reported in the early 1990s, distinguishing it from the hormone's normal thyroidal role. Subsequent clinical studies through the 2000s characterized its kinetics, compared it with CRP, and tested procalcitonin-guided antibiotic strategies, establishing it as a leading infection and sepsis biomarker.

Debates

Can procalcitonin reliably distinguish bacterial from non-bacterial inflammation?

Procalcitonin is more bacterial-selective than CRP, but its sensitivity and specificity vary across settings and it cannot definitively rule infection in or out on its own, so its standalone diagnostic value remains debated.

Key figures

• Beat Müller
• Mirjam Christ-Crain
• Frank Brunkhorst
• Jean-Louis Vincent

Seminal works

• christ-crain-2004
• wacker-2013

Frequently asked questions

Why is procalcitonin considered more specific for bacterial infection than CRP?

Its production is induced strongly by bacterial products and tends to be suppressed by the interferon response seen in viral infection, so it rises more in bacterial disease, although it is still not perfectly specific.

Is procalcitonin a hormone?

It is the precursor of the hormone calcitonin; in systemic bacterial infection the precursor itself accumulates in plasma without the usual hormonal processing, which is why it functions as an infection marker rather than a hormone signal.